Medical Innovations and Business Ventures by Patrick Soon-Shiong

Dr. Patrick Soon-Shiong is a billionaire physician, entrepreneur, and biotech investor, best known for developing the cancer treatment Abraxane and for founding NantWorks, a medical and technology conglomerate. As of 2025, his net worth is estimated at $7.2 billion, stemming from pharmaceutical ventures and holdings in NantKwest (now part of ImmunityBio), which recently secured FDA approval for a new immunotherapy platform. ImmunityBio, valued at over $8 billion, announced successful Phase 3 results in pancreatic and bladder cancer therapies this year.

Soon-Shiong also owns the Los Angeles Times, which he continues to modernize with AI-based personalization and blockchain-verified journalism pilots. He is investing heavily in decentralized clinical data exchanges and next-generation medical diagnostics. His companies manage more than 50 ongoing clinical trials across oncology and infectious diseases. In 2025, he launched a $250 million initiative to combat health inequality through genomic medicine in sub-Saharan Africa. He also increased his ownership stake in several hospital systems, merging genomic research with public health care delivery.